두개내 동맥류 시장 : 시장 규모, 점유율, 성장률, 산업 분석 - 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of intracranial aneurysm Market

The global intracranial aneurysm market is witnessing steady growth due to the rising prevalence of cerebrovascular diseases, increasing awareness of early diagnosis, and rapid advancements in minimally invasive neurovascular treatment technologies. The market was valued at USD 1.74 billion in 2025 and is projected to grow from USD 1.87 billion in 2026 to USD 2.95 billion by 2034, registering a CAGR of 5.90% during the forecast period. North America dominated the market with a 43.70% share in 2025, supported by strong healthcare infrastructure, active research initiatives, and high adoption of advanced aneurysm treatment devices.

Market Overview

An intracranial or cerebral aneurysm is a balloon-like dilation of blood vessels in the brain caused by weakened vessel walls. If ruptured, it can lead to severe internal bleeding and can be life-threatening. Treatment options include microsurgical clipping and minimally invasive endovascular procedures such as coiling, stenting, and flow diversion. Increasing awareness among patients and healthcare providers regarding these treatment approaches is significantly boosting demand for intracranial aneurysm devices globally.

According to the Brain Aneurysm Foundation (2023), approximately 6.7 million people in the U.S. live with an unruptured brain aneurysm, highlighting the large patient pool requiring diagnosis and treatment.

Impact of COVID-19

The COVID-19 pandemic negatively affected the intracranial aneurysm market due to reduced elective neurovascular procedures and disruptions in the supply chain of medical devices. A decline in procedure volumes during the pandemic led to slower market growth. However, the gradual resumption of hospital services and delayed neurovascular interventions helped the market regain stability post-pandemic.

Market Trends

A major trend shaping the market is the growing preference for minimally invasive procedures. Traditional craniotomy and clipping methods are increasingly being replaced by endovascular techniques such as coiling and flow diversion, which reduce recovery time and procedural risks. Technological advancements in flow diverters have expanded their use from complex aneurysms to small and medium-sized lesions, driving higher adoption and encouraging innovation among device manufacturers.

Market Growth Drivers

The increasing prevalence of cerebral aneurysms globally is a key driver of market growth. Advanced imaging technologies such as magnetic resonance angiography and 3D angiography have improved early detection rates, increasing the number of patients seeking treatment. Additionally, strong support from public and private organizations for aneurysm research is accelerating innovation. Research grants and long-term clinical studies are enabling the development of next-generation therapeutic devices with improved safety and efficacy.

Countries such as Japan show a higher risk of aneurysm rupture, which has led to early screening programs and increased demand for aneurysm treatment devices.

Restraining Factors

Despite technological progress, misdiagnosis and high treatment costs remain significant challenges. Treating ruptured aneurysms is substantially more expensive than managing unruptured cases. Moreover, limited awareness, lack of standardized diagnostic guidelines, and inadequate healthcare infrastructure in developing regions contribute to delayed diagnosis, restricting broader market penetration.

Segmentation Analysis

By product type, aneurysm therapeutic devices dominated the market with a 44.39% share in 2026, driven by high adoption of coils, clips, flow diverters, and intravascular devices. Based on aneurysm type, saccular aneurysms accounted for 90.91% of the market in 2026, as they are the most commonly diagnosed form. By end-user, hospitals led the market with a 72.19% share in 2026, owing to the availability of skilled professionals and advanced neurovascular treatment facilities.

Regional Insights

North America generated USD 0.76 billion in 2025, driven by strong awareness programs, early adoption of minimally invasive procedures, and robust R&D activity. Europe followed, supported by EU-funded research initiatives and innovation-driven startups. Asia Pacific is expected to grow at the highest CAGR, due to a high disease burden, expanding healthcare access, and lower surgical costs in countries such as India and China.

Competitive Landscape

The market is highly consolidated, with Stryker, Medtronic, and Terumo Corporation leading globally. These companies are focused on acquisitions, partnerships, and new product launches to strengthen their portfolios. Emerging players are also investing heavily in R&D to establish their presence in the neurovascular devices market.

Conclusion

The global intracranial aneurysm market is poised for consistent growth, expanding from USD 1.74 billion in 2025 to USD 2.95 billion by 2034, driven by rising prevalence of cerebral aneurysms, growing preference for minimally invasive treatments, and continuous technological advancements. While challenges such as misdiagnosis and high treatment costs persist, increasing research funding, improved diagnostic capabilities, and expanding healthcare infrastructure are expected to support sustained market growth throughout the forecast period.

Segmentation By Product Type

• Aneurysm Therapeutic Devices
  • Clips
  • Coils
  • Intravascular Devices
  • Flow Diverter
• Embolization Devices
  • Occlusion Catheters
  • Embolic Agent
• Aspiration Devices
  • Aspiration Catheter
  • Clot Retrieval Device
• Access Devices
  • Micro Catheter
  • Guidewire

By Type

• Saccular aneurysm
• Fusiform aneurysm
• Mycotic aneurysm

By End-User

• Hospitals
• Specialty Clinics
• Others

By Region

• North America (By Product Type, Type, End-User, and Country)
  • U.S.
  • Canada
• Europe (By Product Type, Type, End-User, and Country)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific (By Product Type, Type, End-User, and Country)
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America (By Product Type, Type, End-User, and Country)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, Type, End-User, and Country)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Key Surgical Procedures, 2026
• 4.2. New Product Launches, By Key Players
• 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
• 4.4. Technological Advancement in Intracranial Aneurysm Devices
• 4.5. Impact of COVID-19 on the Market

5. Global Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Aneurysm Therapeutic Devices
    • 5.1.1.1. Clips
    • 5.1.1.2. Coils
    • 5.1.1.3. Intravascular Devices
    • 5.1.1.4. Flow Diverter
  • 5.1.2. Embolization Devices
    • 5.1.2.1. Occlusion Catheters
    • 5.1.2.2. Embolic Agent
  • 5.1.3. Aspiration Devices
    • 5.1.3.1. Aspiration Catheter
    • 5.1.3.2. Clot Retrieval Device
  • 5.1.4. Access Devices
    • 5.1.4.1. Micro Catheter
    • 5.1.4.2. Guidewire
• 5.2. Market Analysis, Insights and Forecast - By Type
  • 5.2.1. Saccular aneurysm
  • 5.2.2. Fusiform aneurysm
  • 5.2.3. Mycotic aneurysm
• 5.3. Market Analysis, Insights and Forecast - By End User
  • 5.3.1. Hospitals
  • 5.3.2. Specialty Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Aneurysm Therapeutic Devices
    • 6.1.1.1. Clips
    • 6.1.1.2. Coils
    • 6.1.1.3. Intravascular Devices
    • 6.1.1.4. Flow Diverter
  • 6.1.2. Embolization Devices
    • 6.1.2.1. Occlusion Catheters
    • 6.1.2.2. Embolic Agent
  • 6.1.3. Aspiration Devices
    • 6.1.3.1. Aspiration Catheter
    • 6.1.3.2. Clot Retrieval Device
  • 6.1.4. Access Devices
    • 6.1.4.1. Micro Catheter
    • 6.1.4.2. Guidewire
• 6.2. Market Analysis, Insights and Forecast - By Type
  • 6.2.1. Saccular aneurysm
  • 6.2.2. Fusiform aneurysm
  • 6.2.3. Mycotic aneurysm
• 6.3. Market Analysis, Insights and Forecast - By End User
  • 6.3.1. Hospitals
  • 6.3.2. Specialty Clinics
  • 6.3.3. Others
• 6.4. Market Analysis - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Aneurysm Therapeutic Devices
    • 7.1.1.1. Clips
    • 7.1.1.2. Coils
    • 7.1.1.3. Intravascular Devices
    • 7.1.1.4. Flow Diverter
  • 7.1.2. Embolization Devices
    • 7.1.2.1. Occlusion Catheters
    • 7.1.2.2. Embolic Agent
  • 7.1.3. Aspiration Devices
    • 7.1.3.1. Aspiration Catheter
    • 7.1.3.2. Clot Retrieval Device
  • 7.1.4. Access Devices
    • 7.1.4.1. Micro Catheter
    • 7.1.4.2. Guidewire
• 7.2. Market Analysis, Insights and Forecast - By Type
  • 7.2.1. Saccular aneurysm
  • 7.2.2. Fusiform aneurysm
  • 7.2.3. Mycotic aneurysm
• 7.3. Market Analysis, Insights and Forecast - By End User
  • 7.3.1. Hospitals
  • 7.3.2. Specialty Clinics
  • 7.3.3. Others
• 7.4. Market Analysis - By Country/Sub-region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Rest of Europe

8. Asia pacific Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Aneurysm Therapeutic Devices
    • 8.1.1.1. Clips
    • 8.1.1.2. Coils
    • 8.1.1.3. Intravascular Devices
    • 8.1.1.4. Flow Diverter
  • 8.1.2. Embolization Devices
    • 8.1.2.1. Occlusion Catheters
    • 8.1.2.2. Embolic Agent
  • 8.1.3. Aspiration Devices
    • 8.1.3.1. Aspiration Catheter
    • 8.1.3.2. Clot Retrieval Device
  • 8.1.4. Access Devices
    • 8.1.4.1. Micro Catheter
    • 8.1.4.2. Guidewire
• 8.2. Market Analysis, Insights and Forecast - By Type
  • 8.2.1. Saccular aneurysm
  • 8.2.2. Fusiform aneurysm
  • 8.2.3. Mycotic aneurysm
• 8.3. Market Analysis, Insights and Forecast - By End User
  • 8.3.1. Hospitals
  • 8.3.2. Specialty Clinics
  • 8.3.3. Others
• 8.4. Market Analysis - By Country/Sub-region
  • 8.4.1. Japan
  • 8.4.2. Australia
  • 8.4.3. China
  • 8.4.4. India
  • 8.4.5. Rest of Asia Pacific

9. Latin America Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Aneurysm Therapeutic Devices
    • 9.1.1.1. Clips
    • 9.1.1.2. Coils
    • 9.1.1.3. Intravascular Devices
    • 9.1.1.4. Flow Diverter
  • 9.1.2. Embolization Devices
    • 9.1.2.1. Occlusion Catheters
    • 9.1.2.2. Embolic Agent
  • 9.1.3. Aspiration Devices
    • 9.1.3.1. Aspiration Catheter
    • 9.1.3.2. Clot Retrieval Device
  • 9.1.4. Access Devices
    • 9.1.4.1. Micro Catheter
    • 9.1.4.2. Guidewire
• 9.2. Market Analysis, Insights and Forecast - By Type
  • 9.2.1. Saccular aneurysm
  • 9.2.2. Fusiform aneurysm
  • 9.2.3. Mycotic aneurysm
• 9.3. Market Analysis, Insights and Forecast - By End User
  • 9.3.1. Hospitals
  • 9.3.2. Specialty Clinics
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Intracranial Aneurysm Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Aneurysm Therapeutic Devices
    • 10.1.1.1. Clips
    • 10.1.1.2. Coils
    • 10.1.1.3. Intravascular Devices
    • 10.1.1.4. Flow Diverter
  • 10.1.2. Embolization Devices
    • 10.1.2.1. Occlusion Catheters
    • 10.1.2.2. Embolic Agent
  • 10.1.3. Aspiration Devices
    • 10.1.3.1. Aspiration Catheter
    • 10.1.3.2. Clot Retrieval Device
  • 10.1.4. Access Devices
    • 10.1.4.1. Micro Catheter
    • 10.1.4.2. Guidewire
• 10.2. Market Analysis, Insights and Forecast - By Type
  • 10.2.1. Saccular aneurysm
  • 10.2.2. Fusiform aneurysm
  • 10.2.3. Mycotic aneurysm
• 10.3. Market Analysis, Insights and Forecast - By End User
  • 10.3.1. Hospitals
  • 10.3.2. Specialty Clinics
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2026)
• 11.2. Company Profiles
  • 11.2.1. Medtronic
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. B. Braun SE
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Integra LifeSciences
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. MicroPort Scientific Corporation
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Stryker
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Johnson & Johnson Services, Inc.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Terumo Corporation (MicroVention Inc.)
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Evasc Neurovascular Enterprises
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Penumbra, Inc.
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)